USTrend Signal
9
mentions (7d)
9
mentions (30d)
Jun 11, 2026
first seen
1
countries
Context & Analysis
This trend "Supreme Court unanimous ruling in Hikma v. Amarin skinny-label case" was detected in the Law & Legal category with a score of 100/100. This trend is experiencing explosive growth and attracting significant attention right now.
Related entities
Source excerpts
* Post author: * Post published:June 4, 2026 * Post category:/// * Post comments: ](https://law.marquette.edu/facultyblog/wp-content/uploads/2011/12/Supreme-Court1.jpg)Just this morning, the Supreme Court issued its , the most recent “skinny-label” case, and it did so unanimously. Justice Jackson, writing for all nine, reversed the Federal Circuit and held that Amarin’s lawsuit against the generic manufacturer Hikma cannot survive a motion to dismiss. I had planned to spread this story across a...
— law.marquette.edu
What sources say
"The Supreme Court unanimously reversed the Federal Circuit and dismissed Amarin's lawsuit against generic manufacturer Hikma in the skinny-label dispute."
"With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic version of Amarin's fish oil-derived..."
"Today, the U.S. Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, unanimously reversing the..."
"A unanimous Supreme Court held that Amarin did not plausibly allege that Hikma's skinny label and marketing actively induced infringement of Vascepa's..."
"On June 4, 2026, the Supreme Court published a long-awaited decision providing guidance to the pharmaceutical industry on the status of so-called “skinny..."
"Below, stakeholders weigh in on the upshot of the ruling and what it means for pharmaceutical innovation going forward."
"Unanimous SCOTUS ruling: The Court voted 9-0 to reverse the Federal Circuit, finding Amarin's claims against Hikma lacked plausible allegations of active..."
"... at SCOTUS in landmark skinny-label ruling. 4 June 2026NewsAmericasMarisa Woutersen. Hikma triumphs at SCOTUS in landmark skinny-label ruling."
"The Supreme Court rules 9–0 in a case led by Justice Jackson, shaping how patent law applies to generic drug “skinny labels.”"